Plasma asymmetrical-dimethyl-arginine (ADMA) as a regulator of vascular redox and nitric oxide bioavailability in human vessels

Samankaltaisia teoksia

• Plasma asymmetrical-dimethyl-arginine (ADMA) regulates nitric oxide bioavailability and vascular superoxide production in human vessels
  Tekijä: Antoniades, C, et al.
  Julkaistu: (2007)
• Plasma asymmetrical-dimethyl-arginine affects eNOS vascular superoxide radical production and nitric oxide bioavailability in human arteries and veins
  Tekijä: Antoniades, C, et al.
  Julkaistu: (2008)
• Association of plasma asymmetrical dimethylarginine (ADMA) with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: implications for endothelial function in human atherosclerosis.
  Tekijä: Antoniades, C, et al.
  Julkaistu: (2009)
• Polymorphism of MTHFR gene affects vascular redox and nitric oxide bioavailability by modifying eNOS coupling
  Tekijä: Antoniades, C, et al.
  Julkaistu: (2008)
• Genetic variability of MTHFR affects vascular redox and nitric oxide bioavailability in human vessels, by modifying eNOS coupling
  Tekijä: Antoniades, C, et al.
  Julkaistu: (2008)